Effect of Topical Application of an NSAID Lateral to the Incision on Postoperative Pain Following Unicompartmental Knee Arthroplasty: A Double-Blind Randomized Controlled Trial

Abstract

Objective: How to minimize postoperative pain following knee replacement surgery has been a great challenge. This study was performed to evaluate the effect of applying a topical nonsteroidal anti-inflammatory drug (NSAID) lateral to the incision for postoperative pain following unicompartmental knee arthroplasty (UKA).

Methods: The randomized controlled trial enrolled 100 patients from August 2023 to January 2024. One hundred patients who underwent UKA were randomized into two groups. The intervention group received a topical NSAID lateral to the incision postoperatively, and the control group received a placebo lateral to the incision postoperatively. The primary outcome measures were the amount of opioid consumption and the visual analogue scale (VAS) score (12, 24, 36, 48, and 72 h after operation) for pain. The secondary outcome measures were the American Knee Society Score (AKSS, preoperation and 1-month follow-up after operation), the time of first analgesic demand, side effects of opioids, operation time, postoperative stay, surgery-related complications, and postoperative incision healing grade. Independent sample t test and paired sample t test were used to compare continuous data. Chi-square test and Fisher’s precision probability tests were used to analyze the categorical data.

Results: Ninety-eight patients (intervention group, 48 patients; control group, 50 patients) were analyzed. Opioid consumption was significantly lower in the intervention group than in the control group during the first 12 h, 12 to 24 h, and 24 to 48 h postoperatively (p < 0.05). The VAS score for pain within 72 h postoperatively was significantly lower in the intervention group than in the control group (p < 0.05). There was no significant difference in the AKSS, operation time, postoperative stay, complications, or postoperative incision healing grade between the two groups. The time of first analgesic demand for patient-controlled analgesia was significantly later in the intervention group than in the control group (p < 0.05). There were fewer side effects of opioids in the intervention group (8.3%) than in the control group (18.0%).

Conclusion: Postoperative application of topical NSAIDs lateral to the incision is an effective and safe method for pain management after UKA, helping to decrease the pain score and reduce opioid consumption postoperatively with no increase in side effects.

Keywords

Osteoarthritis / Postoperative pain / Randomized controlled trial / Topical nonsteroidal anti-inflammatory drug / Unicompartmental knee arthroplasty

References

[1] Price AJ, Alvand A, Troelsen A, Katz JN, Hooper G, Gray A, et al. Knee replacement. Lancet. 2018; 392: 1672–1682.

[2] Murray DW, Parkinson RW. Usage of unicompartmental knee arthroplasty. Bone Joint J. 2018; 100-B: 432–435.

[3] Zhang J, Ng N, Scott CEH, Blyth MJG, Haddad FS, Macpherson GJ, et al. Robotic arm-assisted versus manual unicompartmental knee arthroplasty: a systematic review and meta-analysis of the MAKO robotic system. Bone Joint J. 2022; 104-B: 541–548.

[4] Tay ML, Young SW, Frampton CM, Hooper GJ. The lifetime revision risk of unicompartmental knee arthroplasty. Bone Joint J. 2022; 104-B: 672–679.

[5] Essving P, Axelsson K, Aberg E, et al. Local infiltration analgesia versus intrathecal morphine for postoperative pain management after total knee arthroplasty: a randomized controlled trial. Anesth Analg. 2011; 113: 926–933.

[6] Nielsen NI, Kehlet H, Gromov K, Troelsen A, Husted H, Varnum C, et al. High-dose dexamethasone in low pain responders undergoing total knee arthroplasty: a randomised double-blind trial. Br J Anaesth. 2023; 130: 322–330.

[7] Stokes JR, Wang A, Poulton L, Rombach I, Pandit H, Knight R. Study of peri-articular Anaesthetic for replacement of the knee (SPAARK): statistical analysis plan for a randomised controlled trial assessing the effectiveness of peri-articular liposomal bupivacaine plus bupivacaine hydrochloride compared with bupivacaine hydrochloride alone. Trials. 2021; 22: 346.

[8] Li J-W, Ma Y-S, Xiao L-K. Postoperative pain Management in Total Knee Arthroplasty. Orthop Surg. 2019; 11: 755–761.

[9] Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet. 2019; 393: 1537–1546.

[10] Kehlet H. Postoperative pain, analgesia, and recovery-bedfellows that cannot be ignored. Pain. 2018; 159(Suppl 1): S11–S16.

[11] Li C, Chen Y, Han K, Zhang Y, Qi L, Liu X, et al. Does intraoperative multi-drug wound infiltration relieve postoperative pain following single-level TLIF surgery? A randomized controlled trial. Pain Phys. 2023; 26: 13–19.

[12] Kraiwattanapong C, Arnuntasupakul V, Kantawan R, Woratanarat P, Keorochana G, Langsanam N. Effect of multimodal drugs infiltration on postoperative pain in Split laminectomy of lumbar spine: a randomized controlled trial. Spine (Phila Pa 1976). 2020; 45: 1687–1695.

[13] Engelman DT, Ben Ali W, Williams JB, Perrault LP, Reddy VS, Arora RC, et al. Guidelines for perioperative Care in Cardiac Surgery: enhanced recovery after surgery society recommendations. JAMA Surg. 2019; 154: 755–766.

[14] Debono B, Wainwright TW, Wang MY, Sigmundsson FG, Yang MMH, Smid-Nanninga H, et al. Consensus statement for perioperative care in lumbar spinal fusion: enhanced recovery after surgery (ERAS(R)) society recommendations. Spine J. 2021; 21: 729–752.

[15] Varrassi G, Yeam CT, Rekatsina M, Pergolizzi JV, Zis P, Paladini A. The expanding role of the COX inhibitor/opioid receptor agonist combination in the Management of Pain. Drugs. 2020; 80: 1443–1453.

[16] Keshwani S, Grande I, Maguire M, Goodin A, Vouri SM, Hincapie-Castillo JM. Trends in use of prescription nonsteroidal anti-inflammatory medications before vs after implementation of a Florida law restricting opioid prescribing for acute pain. JAMA Netw Open. 2021; 4: e2113383.

[17] Frauenknecht J, Kirkham KR, Jacot-Guillarmod A, Albrecht E. Analgesic impact of intra-operative opioids vs. opioid-free anaesthesia: a systematic review and meta-analysis. Anaesthesia. 2019; 74: 651–662.

[18] Stiller CO, Hjemdahl P. Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials. J Intern Med. 2022; 292: 557–574.

[19] Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016; 45: S18–S21.

[20] Elsarrag M, Soldozy S, Patel P, Norat P, Sokolowski JD, Park MS, et al. Enhanced recovery after spine surgery: a systematic review. Neurosurg Focus. 2019; 46: E3.

[21] Gessler F, Mutlak H, Tizi K, Senft C, Setzer M, Seifert V, et al. Postoperative patient-controlled epidural analgesia in patients with spondylodiscitis and posterior spinal fusion surgery. J Neurosurg Spine. 2016; 24: 965–970.

[22] Yan WD. Gutted about opioids the microbiome may have an influence on addiction. Nat Med. 2018; 24: 1630–1632.

[23] Kjaergaard M, Moiniche S, Olsen KS. Wound infiltration with local anesthetics for post-operative pain relief in lumbar spine surgery: a systematic review. Acta Anaesthesiol Scand. 2012; 56: 282–290.

[24] Perera AP, Chari A, Kostusiak M, Khan AA, Luoma AMV, Casey ATH. Intramuscular local anesthetic infiltration at closure for postoperative analgesia in lumbar spine surgery: a systematic review and meta-analysis. Spine (Phila Pa 1976). 2017; 42: 1088–1095.

[25] O’Neill P, Knickenberg C, Bogahalanda S, Booth AE. Use of intrathecal morphine for postoperative pain relief following lumbar spine surgery. J Neurosurg. 1985; 63: 413–416.

[26] Kanna DR, Jakkepally DS, Shetty DAP, Rajasekaran DS. A randomised controlled study on epidural morphine and bupivacaine for post-operative analgesia after transforaminal lumbar interbody fusion. Global Spine J. 2023; 13: 1926–1931.

[27] Schenk MR, Putzier M, Kugler B, et al. Postoperative analgesia after major spine surgery: patient-controlled epidural analgesia versus patient-controlled intravenous analgesia. Anesth Analg. 2006; 103: 1311–1317.

[28] Levy N, Santer P, Zucco L, Nabel S, Korsunsky G, Ramachandran SK. Evaluation of early postoperative intravenous opioid rescue as a novel quality measure in patients who receive thoracic epidural analgesia: a retrospective cohort analysis and prospective performance improvement intervention. BMC Anesthesiol. 2021; 21: 120.

[29] Sultan P, Gutierrez MC, Carvalho B. Neuraxial morphine and respiratory depression: finding the right balance. Drugs. 2011; 71: 1807–1819.

[30] Clarke J. Topical NSAIDs come out top for knee OA. Nat Rev Rheumatol. 2021; 17: 508.

[31] Zhao D, Chen Z, Hu S, Lin J, Shao Z, Wang G, et al. Efficacy and safety of loxoprofen hydrogel transdermal patch versus loxoprofen tablet in Chinese patients with myalgia: a double-blind, double-dummy, parallel-group, randomized, controlled, non-inferiority trial. Clin Drug Investig. 2019; 39: 369–377.

RIGHTS & PERMISSIONS

2024 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.